Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 4534387, 10 pages
https://doi.org/10.1155/2017/4534387
Research Article

Guanxintai Exerts Protective Effects on Ischemic Cardiomyocytes by Mitigating Oxidative Stress

1Department of Cardiovascular Medicine, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin 150001, China
2Department of Coronary Care Unit, The First Hospital of Harbin, 151 Diduan Street, Daoli District, Harbin 150000, China
3Department of Cardiovascular Medicine, The First People’s Hospital of Luoyang, 88 East Zhongzhou Road, Luoyang 471000, China
4Department of Cardiovascular Medicine, Heilongjiang Province Land Reclamation Headquarters General Hospital, 235 Hashuang Road, Nangang District, Harbin 150088, China

Correspondence should be addressed to Lu Fu; moc.361@aidanuluf

Received 7 June 2017; Accepted 9 August 2017; Published 17 September 2017

Academic Editor: Haifa Qiao

Copyright © 2017 Jing Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. D. White and D. P. Chew, “Acute myocardial infarction,” The Lancet, vol. 372, no. 9638, pp. 570–584, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Zhou, C.-C. Chuang, and L. Zuo, “Molecular characterization of reactive oxygen species in myocardial ischemia-reperfusion injury,” BioMed Research International, vol. 2015, Article ID 864946, 9 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Sirker, M. Zhang, and A. M. Shah, “NADPH oxidases in cardiovascular disease: Insights from in vivo models and clinical studies,” Basic Research in Cardiology, vol. 106, no. 5, pp. 735–747, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Wang and D. L. Cai, “Clinical observation on the treatment of unstable angina pectoris with Guanxintai pills,” Heilongjiang Medicine and Pharmacy, vol. 34, no. 3, p. 104, 2011. View at Google Scholar
  5. Y. Z. Zhang, “Observation of curative effect of Guanxintai pills on angina pectoris,” Clinical Rational Drug Use, vol. 5, no. 2C, pp. 74-75, 2012. View at Google Scholar
  6. X. P. Bai, “Clinical observation on the treatment of unstable angina pectoris with Guanxintai,” Modern Journal of Integrated Traditional Chinese and Western Medicine, vol. 20, no. 22, pp. 2763–2766, 2011. View at Google Scholar
  7. L. Q. Song, X. D. Zhang, L. P. Zhao, M. L. Zhang, X. H. Han, and D. Sun, “Observation of curative effect of Guanxintai on angina pectoris,” Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease, vol. 20, no. 3, p. 464, 2012. View at Google Scholar
  8. Y. H. Qi, M. L. Zhang, and L. Yin, “The 34 cases of the patients with ventricular premature beats treated with Guanxintai and Amiodarone Hydrochloride tablets,” Guide of China Medicine, vol. 10, no. 10, pp. 301-302, 2012. View at Google Scholar
  9. C. Y. Sun and R. Y. Wang, “Clinical efficacy of Guanxintai pills combined with western medicine on the treatment of angina pectoris combined with hyperlipidemia,” China Medical Engineering, vol. 19, no. 2, pp. 49–51, 2011. View at Google Scholar
  10. F. Y. Guan, H. Li, X. X. Yu, and S. J. Yang, “Effects of astragalus injection on myocardial cell damages due to oxidative stress,” Chinese Journal of Rehabilitation Theory and Practice, vol. 16, no. 9, pp. 830–832, 2010. View at Google Scholar
  11. D. F. Zhang, M. W. Wang, L. S. Wang et al., “Effect of salvianolate on oxidative stress and brain natriuretic peptide in acute myocardial infarction,” Chinese Journal of Integrative Medicine on Cardio/Cerebrovascular Disease, vol. 6, no. 11, pp. 1304–1306, 2008. View at Google Scholar
  12. Y. Zhang, M. Z. Wang, Q. F. Huang et al., “Protective effect of Baoxin pills on myocardial ischemia induced by ligation of coronary artery in rats,” Journal of Beijing University of Traditional Chinese Medicine, vol. 20, no. 1, pp. 31-32, 1997. View at Google Scholar
  13. Y. Zhang, M. Z. Wang, Q. F. Huang et al., “Protective effect of Baoxin pills on myocardial ischemia-reperfusion injury of rats,” Journal of Emergency in Traditional Chinese Medicine, vol. 6, no. 4, pp. 177–179, 1997. View at Google Scholar
  14. Y. P. Fan, M. Z. Wang, X. J. Shi, F. Z. Zhao, and X. D. Jia, “Effects of Baoxin pills on the dynamic of blood lipid, apolipoprotein and lipid peroxide in experimental atherosclerosis,” Journal of Beijing University of Traditional Chinese Medicine, vol. 20, no. 3, pp. 28–31, 1997. View at Google Scholar
  15. G. H. Gao, “The clinical observation of Guanxintai for the treatment of senile coronary heart disease,” Journal of Clinical Rational Drug Use, vol. 5, no. 10C, pp. 61-62, 2012. View at Google Scholar
  16. H. Iwama, S. Amagaya, and Ogihara., “Effect of shosaikoto, a Japanese and Chinese traditional herbal medicinal mixture, on the mitogenic activity of lipopolysaccharide: a new pharmacological testing method,” Journal of Ethnopharmacol, vol. 21, no. 1, pp. 45–53, 1987. View at Google Scholar
  17. M. Hori and K. Nishida, “Oxidative stress and left ventricular remodelling after myocardial infarction,” Cardiovascular Research, vol. 81, no. 3, pp. 457–464, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Zhang, M. Z. Wang, and Q. F. Hong, “The effective of Baoxin pills on myocardial ischemia reperfusion arrhythmia in rats,” Chinese Journal of Gerontology, vol. 5, no. 18, pp. 290–292, 1998. View at Google Scholar
  19. T. Fukui, M. Yoshiyama, A. Hanatani, T. Omura, J. Yoshikawa, and Y. Abe, “Expression of p22-phox and gp91-phox, essential components of NADPH oxidase, increases after myocardial infarction,” Biochemical and Biophysical Research Communications, vol. 281, no. 5, pp. 1200–1206, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. P. A. J. Krijnen, C. Meischl, C. E. Hack et al., “Increased Nox2 expression in human cardiomyocytes after acute myocardial infarction,” Journal of Clinical Pathology, vol. 56, no. 3, pp. 194–199, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Qin, M. Simeone, and R. Patel, “Inhibition of NADPH oxidase reduces myocardial oxidative stress and apoptosis and improves cardiac function in heart failure after myocardial infarction,” Free Radical Biology and Medicine, vol. 43, no. 2, pp. 271–281, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. H. Looi, D. J. Grieve, A. Siva et al., “Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction,” Hypertension, vol. 51, no. 2, pp. 319–325, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Doerries, K. Grote, D. Hilfiker-Kleiner et al., “Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction,” Circulation Research, vol. 100, no. 6, pp. 894–903, 2007. View at Google Scholar
  24. D. W. Infanger, X. Cao, S. D. Butler et al., “Silencing Nox4 in the paraventricular nucleus improves myocardial infarction-induced cardiac dysfunction by attenuating sympathoexcitation and periinfarct apoptosis,” Circulation Research, vol. 106, no. 11, pp. 1763–1774, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Wang, “Mitogen-activated protein kinases in heart development and diseases,” Circulation, vol. 116, no. 12, pp. 1413–1423, 2007. View at Publisher · View at Google Scholar · View at Scopus